ImmuPharma Historical Balance Sheet

IMM Stock

4.00 0.10 2.56%

Trend analysis of ImmuPharma PLC balance sheet accounts such as Total Current Liabilities of 1.4 M or Total Stockholder Equity of 903.1 K provides information on ImmuPharma PLC's total assets, liabilities, and equity, which is the actual value of ImmuPharma PLC to its prevalent stockholders. By breaking down trends over time using ImmuPharma PLC balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining ImmuPharma PLC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ImmuPharma PLC is a good buy for the upcoming year.

ImmuPharma PLC Inventory

1.21

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuPharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About ImmuPharma Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of ImmuPharma PLC at a specified time, usually calculated after every quarter, six months, or one year. ImmuPharma PLC Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ImmuPharma PLC and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ImmuPharma currently owns. An asset can also be divided into two categories, current and non-current.

ImmuPharma PLC Balance Sheet Chart

At present, ImmuPharma PLC's Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 437.1 M, whereas Total Current Liabilities is forecasted to decline to about 1.4 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of ImmuPharma PLC assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ImmuPharma PLC books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on ImmuPharma PLC balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ImmuPharma PLC are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from ImmuPharma PLC's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into ImmuPharma PLC current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuPharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	200.0K	768.5K	691.7K	726.3K
Total Assets	4.0M	2.7M	2.4M	2.3M

Other Current Liab Total Assets

ImmuPharma PLC balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Property Plant And Equipment Net	Accounts Payable	Net Receivables	Property Plant And Equipment Gross	Short Term Debt	Intangible Assets	Property Plant Equipment
Total Assets		-0.38	-0.1	0.99	-0.93	0.39	0.93	0.15	-0.46	0.63	0.93	-0.25	-0.41	0.12	-0.27	0.27	0.97	-0.32	0.67	0.16	-0.35	0.23	-0.1	0.44	0.25	-0.24
Other Current Liab	-0.38		0.66	-0.45	0.33	-0.55	-0.34	-0.08	-0.17	-0.38	-0.34	0.63	0.81	-0.09	0.54	0.5	-0.38	0.68	-0.37	-0.23	0.41	-0.07	-0.06	-0.5	-0.46	0.55
Total Current Liabilities	-0.1	0.66		-0.21	0.21	-0.69	-0.21	0.21	0.15	-0.03	-0.21	0.77	0.77	0.13	0.65	0.77	-0.19	0.78	-0.27	0.32	0.74	0.06	0.43	-0.33	-0.75	0.75
Total Stockholder Equity	0.99	-0.45	-0.21		-0.92	0.42	0.91	0.19	-0.44	0.59	0.91	-0.3	-0.47	0.12	-0.29	0.14	0.95	-0.37	0.64	0.15	-0.41	0.21	-0.13	0.47	0.29	-0.28
Net Debt	-0.93	0.33	0.21	-0.92		-0.57	-1.0	0.07	0.63	-0.49	-1.0	0.43	0.49	0.17	0.46	-0.27	-0.96	0.46	-0.78	0.07	0.46	-0.11	0.26	-0.44	-0.49	0.4
Retained Earnings	0.39	-0.55	-0.69	0.42	-0.57		0.6	-0.59	-0.42	0.37	0.6	-0.95	-0.9	-0.17	-0.95	-0.16	0.57	-0.95	0.76	-0.35	-0.73	0.22	-0.56	0.48	0.83	-0.77
Cash	0.93	-0.34	-0.21	0.91	-1.0	0.6		-0.11	-0.61	0.52	1.0	-0.45	-0.52	-0.17	-0.5	0.29	0.97	-0.49	0.82	-0.07	-0.49	0.12	-0.27	0.48	0.5	-0.41
Non Current Assets Total	0.15	-0.08	0.21	0.19	0.07	-0.59	-0.11		0.41	-0.15	-0.11	0.56	0.33	0.04	0.62	-0.21	-0.1	0.49	-0.39	0.48	0.25	-0.34	0.4	0.1	-0.46	0.44
Non Currrent Assets Other	-0.46	-0.17	0.15	-0.44	0.63	-0.42	-0.61	0.41		-0.07	-0.61	0.3	0.2	0.14	0.39	-0.21	-0.58	0.27	-0.37	0.36	0.2	-0.12	0.25	0.09	-0.5	0.34
Other Assets	0.63	-0.38	-0.03	0.59	-0.49	0.37	0.52	-0.15	-0.07		0.52	-0.32	-0.43	0.41	-0.22	0.3	0.63	-0.38	0.48	0.25	-0.2	0.51	-0.1	0.17	-0.09	-0.19
Cash And Short Term Investments	0.93	-0.34	-0.21	0.91	-1.0	0.6	1.0	-0.11	-0.61	0.52		-0.45	-0.52	-0.17	-0.5	0.29	0.97	-0.49	0.82	-0.07	-0.49	0.12	-0.27	0.48	0.5	-0.41
Common Stock Total Equity	-0.25	0.63	0.77	-0.3	0.43	-0.95	-0.45	0.56	0.3	-0.32	-0.45		0.94	0.19	0.94	0.34	-0.42	0.99	-0.61	0.37	0.69	-0.14	0.5	-0.39	-0.82	0.84
Common Stock Shares Outstanding	-0.41	0.81	0.77	-0.47	0.49	-0.9	-0.52	0.33	0.2	-0.43	-0.52	0.94		0.07	0.88	0.39	-0.52	0.97	-0.63	0.14	0.68	-0.16	0.37	-0.53	-0.74	0.78
Other Current Assets	0.12	-0.09	0.13	0.12	0.17	-0.17	-0.17	0.04	0.14	0.41	-0.17	0.19	0.07		0.23	0.02	0.08	0.14	-0.19	0.3	0.2	0.75	0.14	-0.21	-0.42	0.18
Other Stockholder Equity	-0.27	0.54	0.65	-0.29	0.46	-0.95	-0.5	0.62	0.39	-0.22	-0.5	0.94	0.88	0.23		0.17	-0.45	0.93	-0.73	0.32	0.65	-0.11	0.41	-0.47	-0.88	0.75
Total Liab	0.27	0.5	0.77	0.14	-0.27	-0.16	0.29	-0.21	-0.21	0.3	0.29	0.34	0.39	0.02	0.17		0.29	0.36	0.33	0.08	0.35	0.23	0.13	-0.12	-0.31	0.35
Total Current Assets	0.97	-0.38	-0.19	0.95	-0.96	0.57	0.97	-0.1	-0.58	0.63	0.97	-0.42	-0.52	0.08	-0.45	0.29		-0.47	0.79	0.01	-0.44	0.3	-0.22	0.43	0.41	-0.38
Common Stock	-0.32	0.68	0.78	-0.37	0.46	-0.95	-0.49	0.49	0.27	-0.38	-0.49	0.99	0.97	0.14	0.93	0.36	-0.47		-0.63	0.31	0.71	-0.16	0.5	-0.45	-0.79	0.83
Short Long Term Debt Total	0.67	-0.37	-0.27	0.64	-0.78	0.76	0.82	-0.39	-0.37	0.48	0.82	-0.61	-0.63	-0.19	-0.73	0.33	0.79	-0.63		-0.12	-0.65	0.11	-0.37	0.66	0.61	-0.45
Property Plant And Equipment Net	0.16	-0.23	0.32	0.15	0.07	-0.35	-0.07	0.48	0.36	0.25	-0.07	0.37	0.14	0.3	0.32	0.08	0.01	0.31	-0.12		0.33	-0.07	0.74	0.23	-0.43	0.64
Accounts Payable	-0.35	0.41	0.74	-0.41	0.46	-0.73	-0.49	0.25	0.2	-0.2	-0.49	0.69	0.68	0.2	0.65	0.35	-0.44	0.71	-0.65	0.33		0.08	0.71	-0.64	-0.66	0.55
Net Receivables	0.23	-0.07	0.06	0.21	-0.11	0.22	0.12	-0.34	-0.12	0.51	0.12	-0.14	-0.16	0.75	-0.11	0.23	0.3	-0.16	0.11	-0.07	0.08		-0.22	-0.14	-0.13	-0.13
Property Plant And Equipment Gross	-0.1	-0.06	0.43	-0.13	0.26	-0.56	-0.27	0.4	0.25	-0.1	-0.27	0.5	0.37	0.14	0.41	0.13	-0.22	0.5	-0.37	0.74	0.71	-0.22		-0.25	-0.38	0.51
Short Term Debt	0.44	-0.5	-0.33	0.47	-0.44	0.48	0.48	0.1	0.09	0.17	0.48	-0.39	-0.53	-0.21	-0.47	-0.12	0.43	-0.45	0.66	0.23	-0.64	-0.14	-0.25		0.4	-0.13
Intangible Assets	0.25	-0.46	-0.75	0.29	-0.49	0.83	0.5	-0.46	-0.5	-0.09	0.5	-0.82	-0.74	-0.42	-0.88	-0.31	0.41	-0.79	0.61	-0.43	-0.66	-0.13	-0.38	0.4		-0.76
Property Plant Equipment	-0.24	0.55	0.75	-0.28	0.4	-0.77	-0.41	0.44	0.34	-0.19	-0.41	0.84	0.78	0.18	0.75	0.35	-0.38	0.83	-0.45	0.64	0.55	-0.13	0.51	-0.13	-0.76

Click cells to compare fundamentals

ImmuPharma PLC Account Relationship Matchups

ImmuPharma PLC balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	10.9M	6.0M	4.0M	2.7M	2.4M	2.3M
Other Current Liab	110.7K	158.8K	200.0K	768.5K	691.7K	726.3K
Total Current Liabilities	1.3M	1.6M	1.5M	1.7M	1.9M	1.4M
Total Stockholder Equity	9.7M	4.4M	2.5M	1.1M	950.7K	903.1K
Net Debt	(5.2M)	(1.6M)	(667.7K)	(208.5K)	(239.8K)	(251.7K)
Retained Earnings	(46.0M)	(56.6M)	(61.1M)	(64.1M)	(57.7M)	(54.8M)
Cash	5.9M	1.6M	667.8K	208.5K	187.6K	178.3K
Non Current Assets Total	3.5M	2.7M	1.6M	1.4M	1.6M	1.4M
Non Currrent Assets Other	2.6M	1.8M	772.1K	(1.0)	(1.15)	(1.21)
Other Assets	578.6K	405.5K	486.7K	1.0	1.15	1.09
Cash And Short Term Investments	5.9M	1.6M	667.8K	208.5K	187.6K	178.3K
Common Stock Shares Outstanding	200.2M	251.2M	302.9M	362.0M	416.3M	437.1M
Liabilities And Stockholders Equity	10.9M	6.0M	4.0M	2.7M	2.4M	2.3M
Other Current Assets	1.6M	1.7M	1.5M	1.1M	1.3M	1.3M
Total Liab	1.3M	1.6M	1.5M	1.7M	1.9M	1.7M
Total Current Assets	7.4M	3.3M	2.3M	1.3M	1.2M	1.1M
Common Stock	25.0M	28.5M	29.0M	29.8M	34.3M	36.0M
Short Long Term Debt Total	26.8K	641.8K	700.0	111.0	99.9	94.91
Property Plant And Equipment Net	411.6K	353.0K	389.7K	102.1K	117.4K	181.9K
Accounts Payable	418.1K	1.2M	1.1M	776.2K	892.6K	760.8K
Net Receivables	481.9K	1.1M	166.3K	685.7K	788.5K	950.7K
Property Plant And Equipment Gross	411.6K	1.1M	1.3M	192.3K	221.2K	280.6K
Accumulated Other Comprehensive Income	6.8M	8.7M	9.3M	6.0M	6.9M	7.3M
Short Term Debt	26.8K	641.8K	700.0	111.0	99.9	94.91
Intangible Assets	484.0K	477.6K	473.9K	447.6K	402.8K	477.8K
Property Plant Equipment	164.7K	206.7K	411.6K	353.0K	405.9K	426.2K
Current Deferred Revenue	(175.4K)	(201.0K)	(427.7K)	(380.1K)	(437.1K)	(458.9K)
Non Current Liabilities Total	22.5K	531.9K	1.3M	1.2M	1.5M	0.0
Net Tangible Assets	5.2M	9.6M	3.9M	2.5M	2.8M	5.2M
Short Long Term Debt	98.3K	26.8K	641.8K	700.0	111.0	0.0
Net Invested Capital	10.3M	4.4M	2.5M	1.1M	950.7K	903.1K
Net Working Capital	6.2M	1.8M	887.6K	(321.9K)	(289.7K)	(275.2K)
Capital Stock	25.0M	28.5M	29.0M	29.8M	34.3M	26.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Other Information on Investing in ImmuPharma Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ImmuPharma Historical Balance Sheet

ImmuPharma PLC Inventory

1.21

About ImmuPharma Balance Sheet Analysis

ImmuPharma PLC Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

ImmuPharma PLC balance sheet Correlations

ImmuPharma PLC Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ImmuPharma PLC balance sheet Accounts

Also Currently Popular

Other Information on Investing in ImmuPharma Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Common Stock	+ 0.99	Common Stock Total Equity
Total Current Assets	+ 0.97	Total Assets
Total Current Assets	+ 0.97	Cash
Total Current Assets	+ 0.97	Cash And Short Term Investments

Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Total Current Assets	- 0.96	Net Debt
Common Stock	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.95	Retained Earnings
Common Stock Total Equity	- 0.95	Retained Earnings